Noah Holdings NOAH
$6.11 −$0.41 (-6.29%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.12 +0.18%
Open$6.49
Prev close$6.52
Day range$6.09 – $6.54
Volume1.46M
Market cap$419.43M
P/E (TTM)4.8
Dividend yield–
NOAH Stock News
Headlines matching Noah Holdings or the NOAH ticker, most recent first.
- Noah Holdings: Structural pressures on U.S. Treasury debt are accumulating; overweight gold and hard currencies as institutional hedges
- Citi Sticks to Their Buy Rating for Noah Holdings (NOAH)
- Noah Holdings and Eli Lilly and Co. have reached a BD cooperation milestone, with payments exceeding US$3 billion; however, the positive news failed to boost the stock price, which fell by about 10%.
- Noah Health: Announcement by Noah Health Pharmaceutical Co., Ltd. Regarding the Signing of an R&D Collaboration and License Agreement Between Its Subsidiary and Eli Lilly and Co.
- Hong Kong Market Quick Look | All three major indices declined, with the tech index down 0.41%; tech stocks were mixed, with Xiaomi up 1.5% and Baidu down 2.5%; biotech shares fell, with Noah Health plunging nearly 8%; meanwhile, Haiguangxin rose more than 9% against the market trend. Negative
- Noah Holdings | 144: Notice of proposed sale of securities pursuant to Rule 144
- Noah Holdings Hosts 2026 Global Investor Summit "The Year of Realization: A New Chapter in Global Allocation"
- JP Morgan Maintains Neutral on Noah Holdings, Lowers Price Target to $9.7
- J.P. Morgan Maintains Noah Holdings(NOAH.US) With Hold Rating, Cuts Target Price to $9.7 Negative
- Noah Holdings Files 2026 Interim Report With U.S. SEC
- Rocket | 4: Statement of changes in beneficial ownership of securities-Officer Edwards Noah A.
- Noah Health (688428): Pharmaceutical revenue continues to grow strongly, and its autoimmune pipeline is poised for near-term commercialization.
- Noah Health: Legal Opinion of Fangda Law Firm, Shanghai, Regarding the Fulfillment of Vesting Conditions for the First Vesting Period of the Reserved Grant Portion under Noah Health Pharmaceutical Co., Ltd.\'s 2024 STAR Market Restricted Stock Incentive Plan, and the Cancellation of Certain Restricted Shares
- J.P. Morgan Maintains Noah Holdings(NOAH.US) With Hold Rating, Cuts Target Price to $10.5 Negative
- Noah Holdings (NOAH) Gets a Hold From J.P. Morgan
No comments yet — be the first to weigh in on NOAH.
Sign in to join the discussion.